Drugs in Development
Biospace Clinical Trials Search
Clinical Trials Database compiles R&D activity from biotechnology and
Currently in Clinical Research
A listing of 1,300 drugs in phase II and III clinical trials in the United
States and Canada that include the mechanism of action, indications and
Clinical Trial Results Database
A comprehensive listing of study results reported since January 2000 on
trials throughout the world that include indications, phases and dates.
The U.S. National Institutes of Health,
through its National Library of Medicine, has developed
ClinicalTrials.gov to provide patients, family members and members of
the public current information about clinical research studies.
Current Controlled Trials
Current Controlled Trials is dedicated to promoting the exchange of information
about controlled trials in all areas of healthcare. The site currently
features the metaRegister of Controlled Trials (mRCT) and the Controlled
Trials Links Register. Registration is unrestricted and free.
GlaxoWelcome R & D Pipeline
Listing of GlaxoWelcome clinical trials and drugs in the company's pipeline.
Lists of Drugs in Development
UCSF, as a paticipant in the University
HealthSystem Consortium's (UHC) Clinical Research and Investigator Services
(CRIS) Program, is provided quarterly with lists of drugs in development
for the CRIS Clinical Investigator Networks which, at this time, include
gastroenterology, psychiatry, pulmonary/critical care, and rheumatology.
The most recent lists were received February 2, 1999. To access them,
click on the list for the desired clinical area below. Note: Theses lists
are restricted to UCSF access only. Those outside UCSF will receive an
error message. (Data source: University HealthSystem Consortium, Technology
Assessment and Clinical Research and Investigator Services Programs) Gastroenterology
Drugs In Development,Psychiatry
Drugs In Development Pulmonary
and Critical Care Drugs In Development, Rheumatology
Drugs In Development.
PhRMA: New Medicines in
Link to database and also surveys of new medicines in development in specific
clinical areas and indications.